The striatum is critical for decision-making, movement, and reward processing, functions achieved through subregional cellular and molecular specialization. Striatal cell types and subregions are differentially implicated in neurodegenerative and neuropsychiatric disorders, but the mechanisms underlying these vulnerabilities are poorly understood. Using single-nucleus RNA sequencing across 109 human and 22 mouse samples spanning dorsal and ventral striatum, we provide a comprehensive atlas of subregional neuronal specialization. We define rare neuronal subpopulations and transcriptional gradients along the dorsolateral-ventromedial axis with notable differences between species, suggesting divergent pharmacological targets, connectivity, and disease mechanisms. Integration with genome-wide association and pharmacological studies identifies human-enriched sites of opioid receptor expression and ventral-biased chronic antipsychotic action. Lastly, paired single-cell transcriptomic and somatic trinucleotide repeat expansion measurements identify differences in subregion and neuronal subtype vulnerability in Huntington's disease. Our findings lay the foundation for understanding how striatal cell types and subregions contribute to brain function and neurological disorders.
Raleigh M. Linville, Benjamin T. James, K. Galani et al.· Cell· 0 citations
HIV-1 enters the central nervous system early after infection and establishes a long-lived reservoir that persists despite antiretroviral therapy. Single-cell and single-nucleus RNA sequencing provide powerful approaches to study HIV infection in the human brain, yet standardized and sensitive methods for identifying rare HIV-infected cells in these datasets remain limited. Here, we present a scalable multi-reference framework for detecting HIV RNA–positive cells in human CNS single-nucleus RNA-seq data. The pipeline integrates a modified HIV reference genome, subject-specific variant-updated HIV references, and a comprehensive HIV strain collection to improve viral read recovery and specificity.
We applied this framework to 250 post-mortem brain samples from the SCORCH (Single Cell Opioid Responses in the Context of HIV) consortium spanning 12 brain regions and 102 donors, including people with and without HIV (PWH and PWoH). After screening, 48 samples from 35 donors comprising 559,207 high-quality nuclei were analyzed in depth. We identified 1,939 HIV RNA–positive cells exclusively in samples from PWH. Using conservative thresholds, 908 high-confidence infected cells were retained for downstream analyses. HIV RNA-positive cells were rare overall and strongly enriched in cases with HIV encephalitis. Microglia constituted the predominant infected population (79% of HIV RNA-positive cells), with substantially smaller contributions from oligodendrocytes, astrocytes, and neurons. In non-encephalitic brains, detectable infection was largely restricted to microglia, whereas in encephalitic tissue HIV RNA–positive cells were distributed across multiple CNS (Central Nervous System) lineages. Viral RNA burden followed a long-tailed distribution, with microglia retaining higher HIV transcript counts than other cell types. Recovered HIV reads were concentrated in the U3 region of the 5′ LTR and in the env gene, implicating regulatory and entry-associated regions as focal points of viral diversity in the brain.
Together, these data establish a harmonized framework for identifying rare HIV-infected cells in CNS single-cell datasets and provide large-scale quantitative evidence that microglia represent the dominant and most persistent HIV-infected population in the human brain. This work offers a reference strategy and resource for future NeuroHIV studies aimed at defining, monitoring, and ultimately targeting CNS viral reservoirs.
Yuan-Yuan Cai, Nicholas C. Jacobs, Dana Gabuzda et al.· Virology Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
